Literature DB >> 9098661

A practical guide to the management of complicated urinary tract infection.

L E Nicolle1.   

Abstract

Complicated urinary tract infections are infections in the setting of structural or functional abnormalities of the genitourinary tract. They encompass a wide variety of clinical syndromes and anticipated outcomes. The infecting micro-organisms isolated are more varied and demonstrate a higher prevalence of antimicrobial resistance in complicated compared to uncomplicated urinary tract infections. The usual duration of therapy is 7 to 14 days, although comparative trials to define optimal treatment duration are lacking. Long term success of antimicrobial treatment is dependent upon whether or not the underlying genitourinary abnormality can be corrected. Treatment of complicated urinary tract infections will usually be successful and may be permanent if the underlying abnormality can be corrected. If the underlying abnormality cannot be corrected, failure rates of 50% at 4 to 6 weeks following therapy are expected. Antimicrobial agents are similar to those used to treat uncomplicated urinary tract infection. Certain agents, such as nitrofurantoin, should be avoided for individuals with renal failure. No specific agent or class of agents has consistently demonstrated greater therapeutic efficacy where the infecting organism is susceptible to the given agent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098661     DOI: 10.2165/00003495-199753040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  36 in total

1.  Bacteriuria in patients treated with clean intermittent catheterization.

Authors:  A Bakke; A Digranes
Journal:  Scand J Infect Dis       Date:  1991

2.  Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.

Authors:  G J Sheehan; G K Harding; D A Haase; M J Thomson; B Urias; J K Kennedy; D J Hoban; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

Review 3.  Catheter-associated urinary tract infections.

Authors:  J W Warren
Journal:  Infect Dis Clin North Am       Date:  1987-12       Impact factor: 5.982

4.  Factors predisposing to bacteriuria during indwelling urethral catheterization.

Authors:  R A Garibaldi; J P Burke; M L Dickman; C B Smith
Journal:  N Engl J Med       Date:  1974-08-01       Impact factor: 91.245

5.  Effect of renal function on urinary recovery of orally administered nitrofurantoin.

Authors:  J Sachs; T Geer; P Noell; C M Kunin
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

6.  Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study.

Authors:  J W Warren; H L Muncie; M Hall-Craggs
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  Renal stones and urinary infection: a study of antibiotic treatment.

Authors:  R H Chinn; R Maskell; J A Mead; A Polak
Journal:  Br Med J       Date:  1976-12-11

Review 8.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.

Authors:  M J Gribble; M L Puterman
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

10.  Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole.

Authors:  W M Bennett; R Craven
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

View more
  11 in total

1.  For reliable urine cultures in the detection of complicated urinary tract infection, do we use urine specimens obtained with urethral catheter or a nephrostomy tube?

Authors:  Gülay Dede; Özcan Deveci; Onur Dede; Mazhar Utanğac; Mansur Dağgulli; Necmettin Penbegül; Namık Kemal Hatipoğlu
Journal:  Turk J Urol       Date:  2016-12

Review 2.  A practical guide to antimicrobial management of complicated urinary tract infection.

Authors:  L E Nicolle
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Catheter-related urinary tract infection.

Authors:  Lindsay E Nicolle
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at The Ottawa Hospital.

Authors:  Dawn M Dalen; Rosemary K Zvonar; Peter G Jessamine
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

Review 5.  Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.

Authors:  Culley Carson; Kurt G Naber
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.

Authors:  Seung-Kwan Lim; In Whee Park; Wee Gyo Lee; Hyun Kyung Kim; Young Hwa Choi
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

7.  Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING).

Authors:  Evelyn Shaw; Ibironke Addy; Margaret Stoddart; Christiane Vank; Sally Grier; Irith Wiegand; Leonard Leibovici; Noa Eliakim-Raz; Laura Vallejo-Torres; Stephen Morris; Alasdair MacGowan; Jordi Carratalà; Miquel Pujol
Journal:  BMJ Open       Date:  2016-07-29       Impact factor: 2.692

8.  Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.

Authors:  Jessina C McGregor; George P Allen; David T Bearden
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

9.  Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli.

Authors:  K P Ranjan; Neelima Ranjan
Journal:  Urol Ann       Date:  2014-04

10.  Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study.

Authors:  Veronica A Buonaiuto; Ignacio Marquez; Inmaculada De Toro; Carolina Joya; Juan D Ruiz-Mesa; Raimundo Seara; Antonio Plata; Beatriz Sobrino; Begoña Palop; Juan D Colmenero
Journal:  BMC Infect Dis       Date:  2014-12-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.